Cargando…
Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins
Retinal vein occlusion (RVO) is a common vascular disease of the retina; however, the pathogenesis of RVO is still unclear. Branch RVO (BRVO) commonly occurs at the arteriovenous crossing and it was formerly believed that the diseased artery mechanically compresses the vein. However, it has been rep...
Autores principales: | Kida, Teruyo, Flammer, Josef, Oku, Hidehiro, Konieczka, Katarzyna, Morishita, Seita, Horie, Taeko, Ikeda, Tsunehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187095/ https://www.ncbi.nlm.nih.gov/pubmed/30338274 http://dx.doi.org/10.1016/j.dib.2018.09.070 |
Ejemplares similares
-
Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision
por: Kida, Teruyo, et al.
Publicado: (2016) -
Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion–related macular edema
por: Kida, Teruyo, et al.
Publicado: (2021) -
Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion
por: Kida, Teruyo, et al.
Publicado: (2014) -
Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin
por: Kida, Teruyo, et al.
Publicado: (2021) -
Effects of an Aquaporin 4 Inhibitor, TGN-020, on Murine Diabetic Retina
por: Oosuka, Shou, et al.
Publicado: (2020)